Funding Summary
Total Funding
$200M+
Latest Valuation
Undisclosed
About
Uses combinatorial gene expression to precisely reprogram human iPSCs into any cell type on demand via opti-ox technology.
platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →